Moderna Stock Is Rising After an Upgrade. This Analyst Says It’s Time to Buy.

3 years ago 340

Moderna banal was climbing successful premarket trading Friday aft an expert astatine Piper Sandler upgraded the shares and said the existent terms level was an charismatic introduction point.

Edward Tenthoff upgraded Moderna (ticker: MRNA) banal to Overweight from Neutral but near the people terms unchanged astatine $445, implying a adjacent 31% upside to the shares. Piper Sandler had downgraded the shares to neutral connected Aug. 6.

“Shares...

Read Entire Article

Moderna Stock Is Rising After an Upgrade. This Analyst Says It’s Time to Buy.

Related

How we use Guest Posting as a Powerful Branding Tool

J.P. Morgan’s 2 Stock Picks With Over 80% Upside Potential

A 27-year-old truck driver just became Robinhood’s first big...

Rivian’s Stock Slide Deepens as Operating Chief Steps Down

Trending

Popular

Akamai adds new capabilities and tools for developers

Good News, Bad News on Alzheimer's Vaccine

Muḥammad ibn Mūsā al-Khwārizmī

Southern Baptist Convention Elects Ed Litton as New Presiden...

AHA News: U.S. Appears to Lose Ground in Controlling High Bl...